ArticleNature cancer2022

Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity.

Lei Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.